CompletedPhase 4

A Pilot Study to Evaluate Skin Swabbing With Chlorhexidine to Prevent Skin And Soft Tissue Infections Among People Who Inject Drugs

United States56 participantsStarted 2018-10-01

Plain-language summary

The study examined chlorhexidine gluconate (CHG) swabs as a skin disinfectant in combination with a single-session safer injection training to prevent skin and soft tissue infections (SSTI) in people who inject drugs.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Self-report intravenous drug use within past 30 days Exclusion Criteria: * None

What they're measuring

Frequency of Skin Swabbing

Timeframe: 2 weeks after randomization

Trial details

NCT IDNCT06733506

SponsorGabriel John Culbert

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-05-01

View on ClinicalTrials.gov More Opioid Use Disorder trials